Purchase Order 75N94022P00643

Award Date 8/14/22
Potential Completion Date 8/17/23
Potential Value $90K
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Exton, PA 19341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $117,000.00 firm fixed price purchase order awarded to Frontage Laboratories, Inc. by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The contract is for Frontage Laboratories to provide a range of preclinical research services, including pharmacokinetic testing, in vivo studies, compound synthesis, and fertility assessments, to support the development of new therapies and...
This is a $19,000 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Frontage Laboratories, Inc., a full-service contract research organization (CRO). The contract is for the synthesis of SAMT-247 and an analog compound. Frontage Laboratories has previously supported NIDDK and the National Center for Advancing Translational Sciences through various federal contracts, providing services such as pharmacokinetic testing, in...
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), to Frontage Laboratories, Inc. for $126,850.00. The contract is for research services related to the "Blood Stability and Metabolism of MTS-IV-39 Analogs." This work supports NIDDK's research program and was not set aside for any specific business category. Frontage Laboratories is a full-service contract...
This is a $34,000.00 firm fixed price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Frontage Laboratories, Inc., a full-service contract research organization (CRO), for an intravaginal female fertility study. The contract will run through January 5, 2024. Frontage Laboratories has previously conducted a range of preclinical research services for NIDDK and the National Center for Advancing Translational Sciences, including...
This federal contract award, valued at $51,248.00, was issued by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Polyorg, Inc., a manufacturer of specialty chemicals. The award was a firm fixed-price purchase order for the delivery of 80 grams of A(Bhoc)-OH, 120 grams of C(Bhoc)-OH, and 160 grams of G(Bhoc)-OH, which are key building blocks for the development of thyclotides and cyclopentane peptide nucleic acids. These materials...
This federal contract award, valued at $50,000.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services, to the prime contractor Entrechem SL. The contract is for the purchase of 100 grams each of two specific enantiomers of trans-N-Boc-1,2-tetrahydro-3,4-furandiamine. These chemical compounds are needed as starting materials for the NIDDK's research into developing thyclotides, which...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) awarded a $45,390.05 firm-fixed-price purchase order to Biotage, LLC for a base year plus four option years of maintenance and support services for the Alstra Peptide Synthesizer. This equipment is used by the NIDDK's Laboratory of Chemical Physics to conduct research on protein folding, ligand binding, and peptide aggregation. The solicitation was not competitively bid, as...
The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $10,848.60 firm fixed-price purchase order contract to Life Technologies Corporation of Grand Island, New York. As the prime contractor, Life Technologies Corporation will provide unspecified products or services to the agency between March 15, 2019 and April 14, 2019 to support the National Institute of Diabetes and Digestive and Kidney...
Creagen Inc. was awarded a $80,000 purchase order by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a part of the National Institutes of Health (NIH), to provide services related to a library of bioactive molecules. The contract has a period of performance from July 24, 2023 through September 23, 2023 and utilizes a firm fixed price structure. To be performed in Woburn, Massachusetts, the effort aims to support the NIDDK's research programs through the...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $37,000.00 Firm Fixed Price purchase order to Polyorg, Inc., a for-profit manufacturer located in Leominster, Massachusetts. The contract is for the procurement of Bhoc Nucleobase Acids to support NIDDK's biomedical research. This award was made without competition under the original Request for Quotation (RFQ) number 75N94023Q00088, which had a NAICS code of 541380 with a $19 million size standard. No...

The National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $90,000.00 firm fixed price purchase order contract to Frontage Laboratories, Inc. for the synthesis of thyclotides (R,R). The contract has no set-aside designation and was awarded on August 14, 2022 with an ultimate completion date of August 17, 2023. Frontage Laboratories, a minority-owned, Asian-Pacific American manufacturer of goods, has provided a range of research services to NIDDK and the National Center for Advancing Translational Sciences in the past, including pharmacokinetic testing, in vivo studies, compound synthesis, and fertility assessments. This contract supports NIDDK's work in developing new therapies and investigational drugs.

Generated 1/22/25, 9:36 AM